QAI Ventures CEO Alexandra Beckstein speaking at an event
Quantum is no longer confined to research labs; it’s edging into boardrooms, banks, and biopharma pipelines. Few investors grasp this transition as clearly as Alexandra Beckstein, CEO of QAI Ventures, which has chosen Singapore as its Asia-Pacific headquarters.
In this conversation, Beckstein unpacks why Singapore offers the right mix of policy, talent, and industry appetite to become a launchpad for quantum ventures, how lessons from Europe and North America are being adapted here, and why venture building could be the key to turning patents into profitable, globally competitive companies.
Why Singapore? Beyond the government’s strong quantum push, what specific gaps or opportunities did you see that drove QAI Ventures to set up its Asia-Pacific HQ here?
At QAI Ventures, we take a global approach to investing in quantum tech and advanced computing. Talent, technology, and applications are scarce and globally dispersed, so we continuously scout for emerging hubs that show strong signals of ecosystem maturity.
Singapore combines all the key ingredients: world-class universities, a robust IP regime, strong government commitment through its National Quantum Strategy, and clear industry momentum. A recent example is OCBC’s collaboration with NUS, NTU, and SMU to explore quantum applications in banking – a sector we consider a priority for early adoption.
QAI Ventures has had success in Europe and North America. What lessons from those ecosystems are you directly applying, or avoiding, in Singapore?
I would point out three lessons learnt from our previous work:
- Integration with the ecosystem is key: Success in Switzerland and Canada has shown us that tight integration with academia, startups, corporates, and investors is essential. We are bringing the same approach to Singapore.
- Our global approach in talent scouting and providing access is a core USP: We open our hubs internationally, attracting founders to where industry strengths lie. For example, North American teams join our Basel accelerator to access Europe’s life sciences ecosystem. Singapore offers the same draw for finance and industrials.
- Industry-driven focus pays off: We learned to prioritise verticals with early market fit. That’s why we’re concentrating on Finance, Industrials, and Life Sciences in Singapore, supported by initiatives like our GenQ Hackathon in October, where participants tackle SDG challenges at the intersection of these clusters.
Also Read: DigiCert CEO: Quantum computing’s “ChatGPT moment” is coming
In addition, we see venture building as a critical lever. Accelerator programmes focus on existing startups , but starting a venture building programme allows us to combine IP from Singapore’s research base with our database of over 2,000 quantum patents, so we can form globally competitive ventures here. That’s a new approach we bring to the market for the first time, and we chose Singapore as the first location to do so.
Quantum computing remains largely research-driven. What gives you confidence that quantum ventures in the city-state can move from labs to boardrooms faster than elsewhere?
Singapore has built one of the world’s most coordinated national quantum strategies, backed by long-term funding and public-private partnerships. As a financial and logistics hub, it provides immediate boardroom-level use cases in areas like fraud detection, risk modelling, and secure supply chains. The country’s regulatory clarity and strong IP protection make it easier for ventures to attract global investors and partners. Its compact ecosystem concentrates world-class talent and industry leaders in close proximity, shortening the path from research to pilots.
Combined with Singapore’s tradition of being a living lab for frontier technologies, this makes it uniquely positioned to move quantum ventures from lab to boardroom faster than elsewhere.
Many quantum startups face long commercialisation cycles. How will your venture building programme accelerate research into profitable, globally competitive businesses?
Our unique strength is being an ecosystem builder. We limit each cohort to six founder teams to ensure tailored mentoring, close sparring, and strong connections to corporates, investors, and industry experts.
Quantum startups often face long commercialisation cycles because the leap from lab to market requires both deeptech and industry validation. Our programme shortens that path by pairing researchers with experienced entrepreneurs, industry partners, and early adopters from day one. We focus on market-driven use cases in finance, pharma, logistics, and cybersecurity, ensuring the science is steered toward real customer pain points. With structured support in IP strategy, regulatory readiness, and fundraising, we help teams de-risk their journey and attract global capital faster.
Ultimately, the programme transforms cutting-edge research into profitable, globally competitive businesses by combining scientific excellence with commercial execution.
Which sectors in Singapore (finance, life sciences, industrials) do you see as the first real adopters of QuantumAI?
We see strong potential across all three of them: finance, life sciences, and industrials:
In Singapore, the finance sector is expected to be the first real adopter of QuantumAI. Banks such as HSBC and DBS are already exploring quantum-secure communications and advanced risk modelling, and the potential to apply QuantumAI to fraud detection or faster Monte Carlo simulations for portfolio optimisation makes adoption both commercially attractive and regulatorily relevant.
The life sciences industry is also well-positioned, given Singapore’s ambition to be a global biomedical hub. QuantumAI could accelerate drug discovery by simulating complex molecules far beyond the reach of today’s supercomputers, similar to the recent collaboration between Moderna and IBM on mRNA structure modelling and support precision medicine through the analysis of genomic data.
Finally, industrials and logistics form a natural testbed: the Port of Singapore and Changi Airport already lead globally in digitalisation and are experimenting with quantum-secure networks, as seen in the Port of Rotterdam’s scalable quantum internet pilot.
These examples show how Singapore can move quickly from research to real-world adoption, with finance likely leading, life sciences close behind, and logistics providing large-scale, operational deployments.
Given the competition from other hubs like Tokyo, Sydney, and Hong Kong, what will it take for Singapore to stay ahead?
To stay ahead in a region full of innovation leaders, Singapore must build on its strengths while learning from peers like Tokyo, Sydney, and Hong Kong.
Tokyo brings world-class corporate R&D and long-standing leadership in advanced materials and electronics, while Sydney excels in academic research and deep science talent. Hong Kong continues to serve as a vital financial gateway to China and a bridge to mainland innovation.
Also Read: Quantum computing’s double-edged sword could threaten cybersecurity: Report
Singapore differentiates itself by combining regulatory clarity, strong IP protection, and political stability with dense connectivity between finance, biotech, and logistics industries, all within a compact, highly international ecosystem. Unlike Tokyo, which has deep corporate R&D but slower commercialisation cycles, Singapore’s public-private partnerships allow startups to move from pilot to market much faster. Compared to Sydney’s academic strength, Singapore offers direct access to global banks, biotech multinationals, and world-leading logistics hubs like its port and airport. And while Hong Kong positions itself as a financial hub for China, Singapore has established itself as a trusted global hub with deep international connectivity.
By fostering collaboration across these hubs rather than competition, and by staying true to its tradition as a living lab for frontier technologies like QuantumAI, Singapore can remain the launchpad where global startups and local founders test, scale, and commercialise world-class innovations.
Venture capital in quantum is risky, with some saying it is even speculative. What’s your investment thesis in terms of risk appetite and expected time horizons for returns?
QuantumAI is a frontier field, and risk and opportunity go hand in hand. Our investment thesis is built on de-risking for LPs with a two-sided approach:
With our early-stage fund, we combine capital with our accelerator programme, providing structured mentoring, industry integration, and global exposure to improve market fit and increase survival rates.
With our growth-stage fund, we invest in companies already generating revenue, operating in markets on the cusp of adoption, and with clear exit pathways through M&A or IPO. We believe the next three to four years offer a rare window of opportunity in QuantumAI. Growth-stage investments allow shorter holding periods, faster ROI, and multiple exit options due to strong M&A appetite for IP-rich companies.
At the same time, we don’t just wait for deal flow: through venture building, we create companies from scratch by combining strong IP with entrepreneurial teams. This puts us in a unique position to shape the ecosystem, reduce risk, and capture upside across stages.
The post From labs to boardrooms: QAI Ventures bets on Singapore’s quantum future appeared first on e27.